Ear Disorders the new focus for drug manufacturers

07 Mar Ear Disorders the new focus for drug manufacturers

Roughly 1 in 4 canadians is affected by some degree of hearing loss, and roughly 48 million americans have a degree of meaningful hearing loss. Despite the fact that hearing loss is the third most common chronic condition in North America, drug manufacturers have previously devoted very little attention to the world of hearing and balance disorders. This is beginning to change, as pharmaceutical companies are beginning to research preventative and rehabilitative options for both hearing loss and tinnitus. Read this article for more information!